Bruker EBITDA 2010-2023 | BRKR
Bruker annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Bruker EBITDA for the quarter ending December 31, 2023 was $0.141B, a 9.45% decline year-over-year.
- Bruker EBITDA for the twelve months ending December 31, 2023 was $0.552B, a 5.81% increase year-over-year.
- Bruker 2023 annual EBITDA was $0.552B, a 5.81% increase from 2022.
- Bruker 2022 annual EBITDA was $0.522B, a 3.8% increase from 2021.
- Bruker 2021 annual EBITDA was $0.502B, a 52.84% increase from 2020.
Bruker Annual EBITDA
(Millions of US $) |
| 2023 |
$552 |
| 2022 |
$522 |
| 2021 |
$502 |
| 2020 |
$329 |
| 2019 |
$377 |
| 2018 |
$327 |
| 2017 |
$283 |
| 2016 |
$236 |
| 2015 |
$199 |
| 2014 |
$165 |
| 2013 |
$210 |
| 2012 |
$215 |
| 2011 |
$209 |
| 2010 |
$192 |
| 2009 |
$167 |
Bruker Quarterly EBITDA
(Millions of US $) |
| 2023-12-31 |
$141 |
| 2023-09-30 |
$151 |
| 2023-06-30 |
$112 |
| 2023-03-31 |
$148 |
| 2022-12-31 |
$156 |
| 2022-09-30 |
$152 |
| 2022-06-30 |
$96 |
| 2022-03-31 |
$118 |
| 2021-12-31 |
$148 |
| 2021-09-30 |
$135 |
| 2021-06-30 |
$107 |
| 2021-03-31 |
$111 |
| 2020-12-31 |
$135 |
| 2020-09-30 |
$102 |
| 2020-06-30 |
$57 |
| 2020-03-31 |
$35 |
| 2019-12-31 |
$136 |
| 2019-09-30 |
$107 |
| 2019-06-30 |
$73 |
| 2019-03-31 |
$61 |
| 2018-12-31 |
$123 |
| 2018-09-30 |
$85 |
| 2018-06-30 |
$65 |
| 2018-03-31 |
$54 |
| 2017-12-31 |
$111 |
| 2017-09-30 |
$68 |
| 2017-06-30 |
$51 |
| 2017-03-31 |
$53 |
| 2016-12-31 |
$95 |
| 2016-09-30 |
$60 |
| 2016-06-30 |
$34 |
| 2016-03-31 |
$47 |
| 2015-12-31 |
$84 |
| 2015-09-30 |
$42 |
| 2015-06-30 |
$45 |
| 2015-03-31 |
$29 |
| 2014-12-31 |
$57 |
| 2014-09-30 |
$23 |
| 2014-06-30 |
$50 |
| 2014-03-31 |
$36 |
| 2013-12-31 |
$77 |
| 2013-09-30 |
$47 |
| 2013-06-30 |
$59 |
| 2013-03-31 |
$27 |
| 2012-12-31 |
$56 |
| 2012-09-30 |
$74 |
| 2012-06-30 |
$37 |
| 2012-03-31 |
$48 |
| 2011-12-31 |
$67 |
| 2011-09-30 |
$51 |
| 2011-06-30 |
$53 |
| 2011-03-31 |
$38 |
| 2010-12-31 |
$63 |
| 2010-09-30 |
$49 |
| 2010-06-30 |
$45 |
| 2010-03-31 |
$35 |
| 2009-12-31 |
$86 |
| 2009-09-30 |
$33 |
| 2009-06-30 |
$27 |
| 2009-03-31 |
$21 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.984B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
